SOMERSET, N.J., April 23, 2007 (PRIME NEWSWIRE) -- Juvent Medical, Inc., a leading developer of non-invasive, therapeutic medical devices utilizing Dynamic Motion Therapy(r) ("DMT") technology, announced today that the members of the International Osteoporosis Foundation's (IOF) Committee of Corporate Advisors (CCA) had voted unanimously to add Juvent Medical, Inc. to the Committee.
The CCA is composed of thirty-three corporate members, the majority of whom are in the fields of healthcare and consumer products, and works in active partnership with the IOF to carry out major public awareness, educational and scientific projects. Since some of today's most significant osteoporosis research and development work is being undertaken within the corporate arena, the CCA plays a vital role in helping to prevent and treat osteoporosis.
"We are honored to be accepted as a CCA member, and are looking forward to be working with such eminent companies such as Pfizer, GlaxoSmithKline, Wyeth, and Proctor & Gamble in the ongoing global battle against osteoporosis," said John Moroney, the CEO of Juvent Medical, Inc. "Admittance into the CCA membership is a very significant milestone for our Company."
Juvent Medical, Inc. is a is an innovator and leading provider of noninvasive therapies for the prevention and treatment of bone loss associated with primary & secondary osteoporosis, the maintenance of musculoskeletal stability, the reduction of bone healing time and the enhancement of the circulatory system. For more information, visit http://www.juvent.com.
The International Osteoporosis Foundation (IOF), registered as a not-for-profit, non-governmental foundation in Switzerland, functions as a global alliance of patient, medical and research societies, scientists, health care professionals, and international companies concerned about bone health. IOF headquarters are located in Nyon, Switzerland, with a second secretariat, IOF France, located in Lyon, France. For more information, visit www.iofbonehealth.org
This press release may contain "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and involve risks and uncertainties, which may cause results to differ materially from those set forth in the statements. The forward-looking statements may include statements regarding product development, product potential or financial performance. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. Juvent Medical, Inc. undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect Juvent Medical, Inc.'s business.
Dynamic Motion Therapy (r) is a registered trademark of Juvent Medical, Inc.
The Juvent Medical, Inc. company logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3637